The case for & against
Bull & Bear analysis
Bullish
Evoke plc (LON: EVOK) operates primarily in the gaming and sports betting sector, focusing on innovative digital solutions and operational efficiency to enhance profitability. The company is entering a period of transformation following its all-share takeover by Bally's Intralot S.A. The impending merger presents a strategic opportunity to leverage combined assets for sustained growth in both existing and new markets, making Evoke a notable player in the evolving betting landscape.
Bull says
- ↑H1 2025 revenue £888m up 3% reported, 4% constant currency
- ↑Adjusted EBITDA £166m (+44% YoY) driven by cost efficiencies
- ↑International revenue +13% with standout growth in Romania, Italy
- ↑Operational automation cut costs by £4m, boosting margins
- ↑Merger with Bally's Intralot to expand market reach and scale
- ↑High EBITDA growth and strong momentum factors support valuation
Bear says
- ↓Potential UK gaming tax increases may pressure profit margins
- ↓Rising SG&A and marketing spend risks straining cash flow
- ↓Inconsistent revenue execution across segments may hinder growth
- ↓Sports betting share slipping amid intensifying competition
- ↓Consumer spending volatility and inflationary pressures may reduce engagement
- ↓Leverage ratio remains elevated at 5×, raising debt concerns
Earnings Call · Q4 2022 · Mgmt. Guidance
Updated 09-07-2026neutral
Transcript signals
Bull points
- net product sales were approximately $2.5 million compared with the approximately $1.6 million for the year ended December 31, 2021.
- We nearly doubled our new prescribers in 2022, growing 96%.
- In the fourth quarter alone, we increased new prescribers 43% over Q3.
Bear points
- net loss was approximately $8.5 million or $2.62 per share compared with a net loss of $8.5 million or $3.18 per share for the year ended December 31, 2021.
- We expect that selling general administrative expenses will increase in the future as we continue to progress with commercialization of Gemoti, and we reimburse Eversana from the net profits attained from the sales of Gemoti.
- the cost of goods for the fourth quarter again is substantially higher than the previous three quarters.
Read full transcript analysis ›